$晶泰控股(0222_老虎社区_美港股上老虎

$晶泰控股(02228)$ 2025年，中国医药健康领域迎来从“量变”到“质变”的关键跃升，是政策、技术与产业协同成效，AI制药打破研发“不可能三角”，晶泰2026将迎来史上最佳发展时机

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":518727790297160,"tweetId":"518727790297160","gmtCreate":1767669035074,"gmtModify":1767669037160,"author":{"id":4193625296607780,"idStr":"4193625296607780","authorId":4193625296607780,"authorIdStr":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 2025年，中国医药健康领域迎来从“量变”到“质变”的关键跃升，是政策、技术与产业协同成效，AI制药打破研发“不可能三角”，晶泰2026将迎来史上最佳发展时机</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 2025年，中国医药健康领域迎来从“量变”到“质变”的关键跃升，是政策、技术与产业协同成效，AI制药打破研发“不可能三角”，晶泰2026将迎来史上最佳发展时机</p></body></html>","text":"$晶泰控股(02228)$ 2025年，中国医药健康领域迎来从“量变”到“质变”的关键跃升，是政策、技术与产业协同成效，AI制药打破研发“不可能三角”，晶泰2026将迎来史上最佳发展时机","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/518727790297160","repostId":0,"isVote":1,"tweetType":1,"viewCount":254,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02228"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":154,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}